DMAC vs K · $157.4M cap vs P/E 23, $29.03B cap
DiaMedica Therapeutics Inc (DMAC) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
DMAC does not have a complete income-statement cache yet.
K does not have a complete income-statement cache yet.
DMAC currently screens at market cap $157.4M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the DMAC and K stock pages for the full models.
Not investment advice.